Volume 24, Number 2

Volume 24/2, December 2022, pp. 219-228 |  PDF Kaitlin Fajber Abstract This essay examines the extent to which COVID-19 Vaccines Global Access (COVAX) has been a successful mechanism for global COVID-19 vaccine equity as a component of the…

Volume 24/2, December 2022, pp. 215-218 |  PDF Paul Hunt and Sophie Bradwell-Pollak New Zealand has a well-deserved positive reputation for its handling of the COVID-19 crisis. The early closure of the country’s border in March 2020, combined…

Volume 24/2, December 2022, pp. 211-214 |  PDF Ellen ‘t Hoen The scrambling for access to COVID-19 vaccines by developing countries has reignited the debate on the World Trade Organization’s (WTO) Agreement on Trade-Related Aspects of…

Volume 24/2, December 2022, pp. 205-209 |  PDF Rosalind Turkie Introduction Pharmaceutical companies have the power and the responsibility to help governments realize the human right to health for all, yet there are egregious…

Volume 24/2, December 2022, pp. 191-204 |  PDF Katrina Perehudoff and Jennifer Sellin Abstract Facing the unmet need for new, affordable medicines for public health crises, how should states’ duty to ensure that everyone shares in the…

Volume 24/2, December 2022, pp. 159-175 |  PDF Jillian Kohler, Anna Wong, and Lauren Tailor Abstract Throughout the COVID-19 pandemic, international access to COVID-19 vaccines and other health technologies has remained highly asymmetric.…